Clinical Trial Update: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the experimental compound NNC0148-0000-0287 in healthy subjects ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0148-0000-0287

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED